MedTrace Logo

Project QueST 2023: Queer Survivors of Trauma

NCT05569915 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2026-03-20

No results posted yet for this study

Summary

This study aims to test the initial efficacy of tailored online writing interventions specifically designed for sexual minority women, transgender individuals, and/or nonbinary people to target the primary outcomes: posttraumatic stress disorder (PTSD) symptom severity and hazardous drinking.

Conditions

  • Stress Disorders, Post-Traumatic
  • Drinking Heavy

Interventions

BEHAVIORAL

Trauma Expressive Writing

Participants assigned to the trauma condition will write about an experience of trauma for 15 to 20 minutes per day across five consecutive days.

BEHAVIORAL

Stigma Expressive Writing

Participants assigned to the stigma condition will write about an experience of stigma or bias for 15 to 20 minutes per day across five consecutive days.

BEHAVIORAL

Control

Participants assigned to the control condition will write about their days for 15 to 20 minutes per day across five consecutive days. This control condition is standard across many expressive writing studies.

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Massachusetts General Hospital

    collaborator OTHER

  • Syracuse University

    lead OTHER

Principal Investigators

  • Jillian R Scheer, PhD · Syracuse University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05569915 on ClinicalTrials.gov